Scilex Holding (SCLX) Free Cash Flow (2020 - 2026)
Scilex Holding (SCLX) posted quarterly Free Cash Flow of -$1.7 million for Q1 2026, down 128.5% year-over-year from $6.0 million in Q1 2025, and up 90.21% quarter-over-quarter from -$17.5 million in Q4 2025.
Scilex Holding (SCLX) Free Cash Flow (2020 - 2026) Analysis & Trends
Scilex Holding's Free Cash Flow history runs 7 years deep, the most recent figure standing at -$1.7 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 128.5% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at -$3.9 million (down 124.42% YoY), while the FY2025 annual figure was $3.8 million, down 80.29% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$1.7 million, up from -$17.5 million in the prior quarter.
- The five-year high for Free Cash Flow was $9.4 million in Q1 2024, with the low at -$17.5 million in Q4 2025.
- The 5-year median for Free Cash Flow is $2.3 million (2024), against an average of -$1.1 million.
- Peak annual rise in Free Cash Flow reached 2155.23% in 2022, while the deepest fall reached 2136.1% in 2022.
- Scilex Holding's Free Cash Flow stood at -$760000.0 in 2022, then slumped by 602.5% to -$5.3 million in 2023, then jumped by 148.02% to $2.6 million in 2024, then slumped by 782.02% to -$17.5 million in 2025, then surged by 90.21% to -$1.7 million in 2026.
- Business Quant data shows SCLX's Free Cash Flow at -$1.7 million in Q1 2026, -$17.5 million in Q4 2025, and $8.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 7.30 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 3.11 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 4.48 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 5.56 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | -1.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 3.49 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 3.43 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 302.00 Mn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 440.07 Mn |
| 10 | Scilex Holding | 39.22 Mn | -73.57 Mn | 3.97 Mn | -7.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.71 Mn |
| Mar 31, 2026 | -1.71 Mn |
| Dec 31, 2025 | -17.49 Mn |
| Dec 31, 2025 | -17.49 Mn |
| Sep 30, 2025 | 8.24 Mn |
| Sep 30, 2025 | 8.24 Mn |
| Jun 30, 2025 | 7.05 Mn |
| Jun 30, 2025 | 7.05 Mn |
| Mar 31, 2025 | 6.01 Mn |
| Mar 31, 2025 | 6.01 Mn |
| Dec 31, 2024 | 2.56 Mn |
| Dec 31, 2024 | 2.56 Mn |
| Sep 30, 2024 | 5.11 Mn |
| Sep 30, 2024 | 5.11 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 9.36 Mn |
| Mar 31, 2024 | 9.36 Mn |
| Dec 31, 2023 | -5.34 Mn |
| Dec 31, 2023 | -5.34 Mn |